Summit Securities Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.3K | Sell |
211
-24,817
| -99% | -$2.38M | ﹤0.01% | 537 |
|
|
2025
Q4 | $2.4M | Buy |
25,028
+22,819
| +1,033% | +$2.22M | 0.31% | 61 |
|
|
2025
Q3 | $210K | Buy |
2,209
+1,345
| +156% | +$124K | 0.04% | 263 |
|
|
2025
Q2 | $75.3K | Buy |
+864
| New | +$73.3K | 0.01% | 416 |
|
|
2025
Q1 | – | Sell |
-2,300
| Closed | -$184K | – | 987 |
|
|
2024
Q4 | $184K | Sell |
2,300
-3,600
| -61% | -$312K | 0.04% | 191 |
|
|
2024
Q3 | $531K | Buy |
+5,900
| New | +$496K | 0.14% | 92 |
|
|
2024
Q1 | – | Sell |
-15,300
| Closed | -$1.26M | – | 737 |
|
|
2023
Q4 | $1.26M | Buy |
+15,300
| New | +$1.17M | 0.11% | 118 |
|
|
2023
Q3 | – | Sell |
-1,840
| Closed | -$162K | – | 847 |
|
|
2023
Q2 | $162K | Sell |
1,840
-772
| -30% | -$66.5K | 0.02% | 239 |
|
|
2023
Q1 | $211K | Sell |
2,612
-2,791
| -52% | -$227K | 0.02% | 212 |
|
|
2022
Q4 | $420K | Buy |
5,403
+2,032
| +60% | +$165K | 0.02% | 265 |
|
|
2022
Q3 | $272K | Buy |
3,371
+566
| +20% | +$50.9K | 0.02% | 365 |
|
|
2022
Q2 | $252K | Buy |
2,805
+1,854
| +195% | +$188K | 0.03% | 266 |
|
|
2022
Q1 | $106K | Sell |
951
-4,190
| -82% | -$443K | 0.01% | 495 |
|
|
2021
Q4 | $532K | Sell |
5,141
-47,959
| -90% | -$5.55M | 0.02% | 352 |
|
|
2021
Q3 | $6.66M | Buy |
53,100
+51,465
| +3,148% | +$6.66M | 0.52% | 40 |
|
|
2021
Q2 | $203K | Sell |
1,635
-2,965
| -64% | -$372K | 0.02% | 655 |
|
|
2021
Q1 | $543K | Sell |
4,600
-15,000
| -77% | -$1.76M | 0.06% | 301 |
|
|
2020
Q4 | $2.3M | Buy |
+19,600
| New | +$2.16M | 0.19% | 125 |
|
|
2020
Q3 | – | Sell |
-5,600
| Closed | -$514K | – | 451 |
|
|
2020
Q2 | $514K | Buy |
+5,600
| New | +$537K | 0.06% | 232 |
|
|
2020
Q1 | – | Sell |
-10,400
| Closed | -$1.18M | – | 398 |
|
|
2019
Q4 | $1.18M | Buy |
10,400
+7,900
| +316% | +$867K | 0.09% | 194 |
|
|
2019
Q3 | $272K | Buy |
+2,500
| New | +$261K | 0.02% | 265 |
|
|
2019
Q1 | – | Sell |
-3,100
| Closed | -$282K | – | 299 |
|
|
2018
Q4 | $282K | Buy |
3,100
+700
| +29% | +$65.4K | 0.02% | 250 |
|
|
2018
Q3 | $236K | Buy |
+2,400
| New | +$222K | 0.09% | 136 |
|
|
2018
Q1 | – | Sell |
-3,300
| Closed | -$266K | – | 205 |
|
|
2017
Q4 | $266K | Buy |
3,300
+500
| +18% | +$40K | 0.03% | 137 |
|
|
2017
Q3 | $218K | Buy |
+2,800
| New | +$232K | 0.04% | 186 |
|
|
2016
Q1 | – | Sell |
-3,710
| Closed | -$285K | – | 265 |
|
|
2015
Q4 | $285K | Buy |
+3,710
| New | +$279K | 0.09% | 150 |
|
|
2015
Q3 | – | Sell |
-3,165
| Closed | -$235K | – | 449 |
|
|
2015
Q2 | $235K | Sell |
3,165
-458
| -13% | -$35K | 0.11% | 67 |
|
|
2015
Q1 | $283K | Sell |
3,623
-198,477
| -98% | -$15M | 0.21% | 66 |
|
|
2014
Q4 | $14.6M | Buy |
202,100
+188,200
| +1,354% | +$13.1M | 4.19% | 5 |
|
|
2014
Q3 | $861K | Buy |
13,900
+2,200
| +19% | +$140K | 0.25% | 75 |
|
|
2014
Q2 | $746K | Buy |
+11,700
| New | +$711K | 0.26% | 62 |
|
|
2014
Q1 | – | Sell |
-15,700
| Closed | -$901K | – | 513 |
|
|
2013
Q4 | $901K | Buy |
+15,700
| New | +$890K | 0.16% | 76 |
|
Other funds holding MDT
VCM
VPM
Summit Securities Group's MDT Position: Q1 2026 in Review
Summit Securities Group reduced its Medtronic (MDT) stake by 99% in Q1 2026, selling an estimated $2.38M and leaving 211 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #537.
Summit Securities Group first reported a position in MDT in Q4 2013 and has held it in 32 quarters since. The position peaked at $14.6M in Q4 2014. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Summit Securities Group held 211 shares of Medtronic worth $18.3K as of Q1 2026.
- Summit Securities Group sold 24,817 Medtronic shares in Q1 2026, an estimated $2.38M.
- Medtronic made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #537 holding.
- Summit Securities Group first reported a position in Medtronic in Q4 2013 and has held it in 32 quarters since.
- Summit Securities Group's Medtronic position peaked at $14.6M in Q4 2014.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.